MedTrace Logo

Epidemiological Study of Colorectal Cancer in WuHan

NCT01863303 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2013-05-27

No results posted yet for this study

Summary

The incidence risk of colorectal cancer （CRC） is increasing at 4.2% year by year in China. Most effective way to reduce the death rate of CRC patients is to diagnose in quite an early stage. QiaoKou District is a chemical industry Zone of Wuhan with a long history, which has few data of CRC epidemiology. The investigators design the primary CRC screening for this district by healthy questionnaire, Fecal Occult Blood Test(FOBT) and colonoscopy. HanYang Areo has been chosen as Control for its non-industry environment.The crowd would be screen biennially. The high risk group would be intervened, such as resection of polyps or other specific treatment. A follow-up registration database has been built for analysis the relationship between incidence or death rate to high risk factors, such as age, life environment, lifestyles, base diseases and family history of cancer.

This study will provide some epidemiology dates of CRC to the local Government, and assist the governor to built a more effective screening system of CRC.

Conditions

Sponsors & Collaborators

  • Wuhan University

    collaborator OTHER

  • Hubei Cancer Hospital

    collaborator OTHER

  • Huazhong University of Science and Technology

    collaborator OTHER

  • Wuhan Iron and Steel Workers' Hospital

    collaborator OTHER

  • Wuhan Pu-Ai Hospital

    lead OTHER

Principal Investigators

  • Yan Li, doctor · Zhongnan hospital of Wuhan university, China

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2017-06-30
Completion
2018-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01863303 on ClinicalTrials.gov